{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:03:24Z","timestamp":1778123004288,"version":"3.51.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Most of the infected individuals have recovered without complications, but a few patients develop multiple organ involvements. Previous reports suggest an association between COVID-19 and various inflammatory myopathies, in addition to autoimmune diseases. COVID-19 has been known to exacerbate preexisting autoimmune diseases and trigger various autoantibodies and autoimmune disease occurrence. Here we report a case of complicated COVID-19 with anti-synthetase autoantibodies (ASSs) presenting with skin rash, muscle weakness, and interstitial lung disease (ILD) and subsequently diagnosed with dermatomyositis (DM). A 47-year-old Japanese male patient without any previous history of illness, including autoimmune diseases, presented with a high fever, sore throat, and cough. Oropharyngeal swab for SARS-Cov-2 polymerase chain reaction tested positive. He was isolated at home and did not require hospitalization. However, his respiratory symptoms continued, and he was treated with prednisolone (20 mg\/day) for 14 days due to the newly developing interstitial shadows over the lower lobes of both lungs. These pulmonary manifestations remitted within a week. He presented with face edema and myalgia 4 weeks later when he was off corticosteroids. Subsequently, he presented with face erythema, V-neck skin rash, low-grade fever, and exertional dyspnea. High-resolution computed tomography of the chest showed ILD. Biochemical analysis revealed creatine kinase and aldolase elevations, in addition to transaminases. Anti-aminoacyl tRNA synthetase (ARS) was detected using an enzyme-linked immunosorbent assay (170.9 U\/mL) (MESACUP\u2122 (Medical &amp;amp; Biological Laboratories, Japan), and the tRNA component was identified as anti-PL-7 and anti-Ro-52 antibodies using an immunoblot assay [EUROLINE Myositis Antigens Profile 3 (IgG), Euroimmun, L\u00fcbeck,Germany]. The patient was diagnosed with DM, especially anti- synthase antibody syndrome based on the presence of myositis-specific antibodies, clinical features, and pathological findings. The present case suggests that COVID-19 may have contributed to the production of anti-synthetase antibodies (ASAs) and the development of <jats:italic>de novo<\/jats:italic> DM. Our case highlights the importance of the assessment of patients who present with inflammatory myopathy post-COVID-19 and appropriate diagnostic work-up, including ASAs, against the clinical features that mimic DM after post-COVID-19.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1002329","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T05:09:34Z","timestamp":1666588174000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["New-onset dermatomyositis following COVID-19: A case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Hiroshi","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Sasajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Temmoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ejiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (Covid-19): A review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00218-6","article-title":"The covid-19 puzzle: Deciphering pathophysiology and phenotypes of a new disease entity","volume":"9","author":"Osuchowski","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000776","article-title":"Covid-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-mda 5 dermatomyositis, including potential covid-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021107826","article-title":"Sars-Cov-2 sensing by rig-I and Mda5 links epithelial infection to macrophage inflammation","volume":"40","author":"Thorne","year":"2021","journal-title":"EMBO J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: Understanding covid-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668725","article-title":"Complement anaphylatoxins and inflammatory cytokines as prognostic markers for covid-19 severity and in-hospital mortality","volume":"12","author":"Alosaimi","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The sars-Cov-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with covid-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.05.004","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"40","author":"Long","year":"2019","journal-title":"Clin Chest Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000844","article-title":"Environmental triggers for connective tissue disease: The case of covid-19 associated with dermatomyositis-specific autoantibodies","volume":"33","author":"De Santis","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: A comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: New and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00002015","article-title":"Idiopathic inflammatory myopathies and the lung","volume":"24","author":"Lega","year":"2015","journal-title":"Eur Respir Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105115","article-title":"Hla association with the susceptibility to anti-synthetase syndrome","volume":"88","author":"Remuzgo-Martinez","year":"2021","journal-title":"Joint Bone Spine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200370","article-title":"Time course of lung changes at chest ct during recovery from coronavirus disease 2019 (Covid-19)","volume":"295","author":"Pan","year":"2020","journal-title":"Radiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01388-0","article-title":"Anti-synthetase syndrome: A rare and challenging diagnosis for bilateral ground-glass opacities-a case report with literature review","volume":"21","author":"Alfraji","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.3390\/cells10123592","article-title":"New onset of autoimmune diseases following covid-19 diagnosis","volume":"10","author":"Gracia-Ramos","year":"2021","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05691-x","article-title":"Covid-19 and the clinical course of rheumatic manifestations","volume":"40","author":"Ahmed","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747116","article-title":"Covid-19 disease and dermatomyositis: A mini-review","volume":"12","author":"Qian","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11926-021-01023-9","article-title":"Covid-19 and myositis: What we know so far","volume":"23","author":"Saud","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset igg autoantibodies in hospitalized patients with covid-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of covid-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2001618","DOI":"10.1183\/13993003.01618-2020","article-title":"Similarities between covid-19 and anti-Mda5 syndrome: What can we learn for better care","volume":"56","author":"Giannini","year":"2020","journal-title":"Eur Respir J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104799","article-title":"The pro-inflammatory cytokines in covid-19 pathogenesis: What goes wrong","volume":"153","author":"Darif","year":"2021","journal-title":"Microb Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: An important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217522","article-title":"Antibodies against immunogenic epitopes with high sequence identity to sars-Cov-2 in patients with autoimmune dermatomyositis","volume":"79","author":"Megremis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.791348","article-title":"Presence of anti-Mda5 antibody and its value for the clinical assessment in patients with covid-19: A retrospective cohort study","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab129","article-title":"Anti-Pl-7 antisynthetase syndrome presenting as covid-19","volume":"60","author":"Blake","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27003","article-title":"Covid-19-Associated myositis with severe proximal and bulbar weakness","volume":"62","author":"Zhang","year":"2020","journal-title":"Muscle Nerve"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202011_23857","article-title":"Case report of covid-19 in an elderly patient: Could sars-Cov2 trigger myositis","volume":"24","author":"Sacchi","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"SI96","DOI":"10.1093\/rheumatology\/keab290","article-title":"Onset of dermatomyositis in close association with covid-19-a first case reported","volume":"60","author":"Borges","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab872","article-title":"Anti-Nxp2 antibody-positive dermatomyositis developed after covid-19 manifesting as type I interferonopathy","volume":"61","author":"Okada","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2022.1440","article-title":"Covid-19 as potential aggravating factor for the natural course of new onset-dermatomyositis","volume":"74","author":"Faria","year":"2022","journal-title":"Reumatismo"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1002329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T05:09:40Z","timestamp":1666588180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1002329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2022.1002329"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1002329","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"1002329"}}